Skip to main navigation

Secondary Header Menu

  • Publications
  • Newsroom
  • Careers
  • Contact
Cidara TherapeuticsCidara Therapeutics
Menu

Corporate Menu

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
    • Careers
  • Pipeline
  • Antifungal
    • Overview
    • Treatment
    • Prevention
    • Expanded Access Policy
  • Antiviral
    • Overview
    • Influenza
    • HIV, RSV, SARS-CoV-2 and other viruses
  • Investors
    • Overview
    • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Historical Lookup
      • Investment Calculator
    • Corporate Governance
      • Highlights
      • Board of Directors
      • Management Team
      • Committee Composition
    • Press Releases
    • Events and Presentations
      • Events and Presentations
      • Event Calendar
      • Past Events
    • Analyst Coverage
    • Shareholder Services
      • Investor FAQs
      • Information Request
      • E-mail Alerts
      • Investor Contact

Committee Composition

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below. 

 

 

Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Bonnie Basler, Ph.D. Nominating and Corporate Governance Committee
Dan Burgess Audit Committee Nominating and Corporate Governance Committee
Carin Canale-Theakston Compensation Committee
Tim Franson, M.D. Compensation Committee Nominating and Corporate Governance Committee
David Gollaher, Ph.D. Nominating and Corporate Governance Committee
Chrysa Mineo Audit Committee Compensation Committee
Ted Schroeder Audit Committee Compensation Committee
= Chairperson = Member

Investors

  • Overview
  • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Historical Lookup
    • Investment Calculator
    • Tax Filings
  • Corporate Governance
    • Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
  • Press Releases
  • Events and Presentations
    • Past Events
  • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • Investor Contact

Shareholder Tools

  • Print
  • RSS Feeds
  • Email Alerts

Contact Us

Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121

p: (858) 752-6170
e: info@cidara.com

Footer Nav

  • About
  • Pipeline
  • Antifungal
  • Antiviral
  • Publications
  • Newsroom
  • Investors
  • Careers

Social Media

  • SUBSCRIBE

© 2021 Cidara Therapeutics, Inc. | Terms of Use | Privacy and Cookies Policy

Corporate Menu

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
    • Careers
  • Pipeline
  • Antifungal
    • Overview
    • Treatment
    • Prevention
    • Expanded Access Policy
  • Antiviral
    • Overview
    • Influenza
    • HIV, RSV, SARS-CoV-2 and other viruses
  • Investors
    • Overview
    • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Historical Lookup
      • Investment Calculator
    • Corporate Governance
      • Highlights
      • Board of Directors
      • Management Team
      • Committee Composition
    • Press Releases
    • Events and Presentations
      • Events and Presentations
      • Event Calendar
      • Past Events
    • Analyst Coverage
    • Shareholder Services
      • Investor FAQs
      • Information Request
      • E-mail Alerts
      • Investor Contact

Secondary Header Menu

  • Publications
  • Newsroom
  • Careers
  • Contact

Social Media